CompanyGraph
What stands out
- Earnings significantly exceed cash generation
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $15.48B, above the global median of $1.18B
- PositionReturn on equity is 34%, higher than 95% of its Medical Instruments & Supplies peers (median 5.6%)
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
15.48BUSDvs all stocks (USD)
Trailing P/E
11.20xvs Medical Instruments & Supplies peers
Revenue (TTM)
8.31BUSDvs all stocks (USD)
Profit Margin
17.26%vs Medical Instruments & Supplies peers
Beta
0.6710xvs all stocks
52-Week Change
25.34%vs all stocks
Market Capitalization
15.48BUSDvs all stocks (USD)
Enterprise Value
20.47BUSDvs all stocks (USD)
Trailing P/E
11.20xvs Medical Instruments & Supplies peers
Forward P/E
12.67xvs Medical Instruments & Supplies peers
PEG Ratio
5.83xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
1.87xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
3.24xvs Medical Instruments & Supplies peers
Enterprise to Revenue
2.46xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
17.97xvs Medical Instruments & Supplies peers
Gross Margin
58.22%vs Medical Instruments & Supplies peers
Profit Margin
17.26%vs Medical Instruments & Supplies peers
Operating Margin
9.78%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
2.70%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
33.96%vs Medical Instruments & Supplies peers
Revenue (TTM)
8.31BUSDvs all stocks (USD)
Revenue per Share (TTM)
47.79USDUpdated Aug 28, 2026Quarterly Revenue Growth
2.20%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
4.55BUSDvs all stocks (USD)
EBITDA (TTM)
1.00BUSDvs all stocks (USD)
Net Income (TTM)
1.43BUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
2.20%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
209.00MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
489.00MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Aug 28, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Instruments & Supplies peers
Revenue
8.32BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
3.87BUSDFY2025 · Dec 31, 2025Gross Profit
4.45BUSDFY2025 · Dec 31, 2025Operating Income
632.00MUSDvs all stocks (USD)
Pre-tax Income
1.71BUSDFY2025 · Dec 31, 2025Income Tax Expense
157.00MUSDFY2025 · Dec 31, 2025Net Income
1.56BUSDFY2025 · Dec 31, 2025EBIT
2.06BUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.08BUSDFY2025 · Dec 31, 2025Research & Development
739.00MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
3.08BUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
347.00MUSDFY2025 · Dec 31, 2025EPS (Basic)
8.94USDFY2025 · Dec 31, 2025EPS (Diluted)
8.88USDFY2025 · Dec 31, 2025Basic Shares Outstanding
174.10MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
174.10MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
1.56BUSDFY2025 · Dec 31, 2025Operating Cash Flow
1.82BUSDFY2025 · Dec 31, 2025Free Cash Flow
1.45BUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
878.00MUSDFY2025 · Dec 31, 2025Income Tax Paid
181.00MUSDFY2025 · Dec 31, 2025Interest Paid
181.00MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
1.56BUSDFY2025 · Dec 31, 2025Depreciation & Amortization
489.00MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
-120.00MUSDFY2025 · Dec 31, 2025Stock-based Compensation
161.00MUSDFY2025 · Dec 31, 2025Other Non-cash Items
-111.00MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
78.00MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
104.00MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-333.00MUSDFY2025 · Dec 31, 2025Capital Expenditures
-379.00MUSDFY2025 · Dec 31, 2025Net Acquisitions
3.19BUSDFY2025 · Dec 31, 2025Other Investing Activity
-18.00MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
2.80BUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025Long-term Debt Payments
-3.07BUSDFY2025 · Dec 31, 2025Other Financing Charges
13.00MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-3.06BUSDFY2025 · Dec 31, 2025Shares Outstanding
170.11MSharesUpdated Aug 28, 2026Float Shares
144.13MSharesUpdated Aug 28, 2026Shares Short
3.47MSharesUpdated Aug 28, 2026Short Ratio
2.84daysvs all stocks
Short % of Shares Outstanding
2.40%vs all stocks
% Held by Insiders
15.32%vs all stocks
% Held by Institutions
76.00%vs all stocks
Total Cash (MRQ)
403.00MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
2.37USDUpdated Aug 28, 2026Total Debt (MRQ)
5.30BUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
1.10xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
1.02xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
28.22USDUpdated Aug 28, 2026Total Assets
14.29BUSDvs all stocks (USD)
Total Current Assets
3.86BUSDFY2025 · Dec 31, 2025Total Liabilities
9.24BUSDFY2025 · Dec 31, 2025Total Non-current Assets
10.44BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
6.11BUSDFY2025 · Dec 31, 2025Total Current Liabilities
3.14BUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
878.00MUSDFY2025 · Dec 31, 2025Accounts Receivable
1.03BUSDFY2025 · Dec 31, 2025Inventory
1.07BUSDFY2025 · Dec 31, 2025Accounts Payable
687.00MUSDFY2025 · Dec 31, 2025Deferred Revenue
621.00MUSDFY2025 · Dec 31, 2025Other Current Liabilities
634.00MUSDFY2025 · Dec 31, 2025Long-term Debt
5.04BUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
546.00MUSDFY2025 · Dec 31, 2025Common Stock (Book)
2.00MUSDFY2025 · Dec 31, 2025Retained Earnings
1.80BUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
5.05BUSDvs all stocks (USD)
52-Week Low
62.38USDUpdated Aug 28, 202652-Week High
92.71USDUpdated Aug 28, 202652-Week Change
25.34%vs all stocks
Beta
0.6710xvs all stocks
50-Day MA
81.76USDUpdated Aug 28, 2026200-Day MA
76.78USDUpdated Aug 28, 2026Avg 10-Day Volume
1.12MSharesUpdated Aug 28, 2026Avg 30-Day Volume
1.21MSharesUpdated Aug 28, 2026Diluted EPS (TTM)
8.17USDUpdated Aug 28, 2026Other Income / Expense
1.43BUSDFY2025 · Dec 31, 20252 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
FCF Ratios Elevated
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Return on equity is 34%, higher than 95% of its Medical Instruments & Supplies peers (median 5.6%)Significant
Return on equity: 0.34Industry median: 0.06Industry P95: 0.23Peers compared: 109
P/E ratio is 11.2×, lower than 95% of its Medical Instruments & Supplies peers (median 33.04×)Notable
P/E ratio: 11.20Industry median: 33.04Industry P5: 13.07Peers compared: 109
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 1,434,000,000Operating Cash Flow (USD, TTM): 209,000,000
Financial Health
Altman Z-Score 2.3: grey zoneSignificant
Altman Z-Score: 2.30
High earnings qualityNotable
Earnings Quality Score: 0.54
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $15.48B, above the global median of $1.18BNotable
Market cap (USD): 15,478,443,677Global Median: 1,179,398,897.704
Revenue is $8.31B, above the global median of $534.05MNotable
Revenue (USD): 8,310,000,128Global Median: 534,052,387.958
Levered free cash flow is $489M, above the global median of $19.23MNotable
Levered free cash flow (USD): 489,000,000Global Median: 19,234,564.734
Companies that share the same coordination system — how they create, deliver, or capture value.
Zhejiang Juhua Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Huaneng Power International Inc.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Hanmi Semiconductor Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Fabrinet
Tier 1ProductionThroughput-Bound ConversionFlowRule
Coloplast A/S Class B
Tier 1ProductionThroughput-Bound ConversionRule
Lincoln Electric Holdings Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
China Three Gorges Renewables (Group) Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
TBEA Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Guangdong Hec Technology Holding Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Tongfu Microelectronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Corcept Therapeutics Incorporated
2 interpretationsCash-Flow Ratios ElevatedFCF Ratios Elevated
Qnity Electronics, Inc.
2 interpretationsCash-Flow Ratios ElevatedFCF Ratios Elevated
Perella Weinberg Partners
2 interpretationsCash-Flow Ratios ElevatedFCF Ratios Elevated